SinoMab BioScience Limited (3681.HK) HKSE
1.22
+0.02(+1.67%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.22
+0.02(+1.67%)
Currency In HKD
| Market Cap | 1.48B |
| Enterprise Value | 1.48B |
| P/E Ratio | -13.89 |
| PEG Ratio | -0.21 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.84 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -10.16 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.11 |
| Return On Equity | -0.28 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -124.7M |
| Net Income | -102.27M |
| Diluted EPS | -0.08 |
| Total Cash | 382.4M |
| Total Cash/Share | 0.28 |
| Total Debt | 338.64M |
| Total Debt/Equity | 0.67 |
| Current Ratio | 1.91 |
| Book Value Per Share | 0.37 |
| 52-Week Change | -39 |
| 52-Week High | 3.76 |
| 52-Week Low | 1.16 |
| Moving Average 50 Days | 1.52 |
| Moving Average 200 Days | 1.7 |
| Average Volume | 3.6M |
| Shares Outstanding | 1.15B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |